Details up front: 3.33 mg/mL · dulaglutide.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
Which axes does this decision turn on?
Details up front: 3.33 mg/mL · dulaglutide.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
Which axes does this decision turn on?
At 3.33 mg/mL a 0.25 mg draw is 7.5 units on a U-100 barrel and a 2.4 mg draw is 72.1. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. Both land on a readable part of a U-100 barrel, which is the entire point of choosing the diluent volume deliberately rather than pouring in a round number. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.
Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.
Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.
More usefully, dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.
Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.
Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.
The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.
Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.
Check the vial can physically hold the volume before you draw it up.
Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.
Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.
The relevant detail is that for a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.
The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.
Measure a volume you can actually measure. Round numbers, real syringes.
The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.
Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.
Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.
Concentration equals content over volume, and content is not label claim.
edited 17 Dec 2025 by linnea_wahlberg — removed a claim I could not source
Total vial volume is a physical constraint: most 2 mL vials will not take 3 mL of anything.
Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.
Write the concentration on the label at reconstitution, in units per dose.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.